SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-089110
Filing Date
2023-08-09
Accepted
2023-08-09 08:27:22
Documents
14
Period of Report
2023-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2323035d1_8k.htm   iXBRL 8-K 28242
2 EXHIBIT 99.1 tm2323035d1_ex99-1.htm EX-99.1 101339
6 GRAPHIC tm2323035d1_ex99-1img001.jpg GRAPHIC 11500
  Complete submission text file 0001104659-23-089110.txt   331686

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA immu-20230809.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20230809_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20230809_pre.xml EX-101.PRE 22359
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2323035d1_8k_htm.xml XML 3327
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

IRS No.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39580 | Film No.: 231153486
SIC: 2834 Pharmaceutical Preparations